Lars Fruergaard Jørgensen
Lars Fruergaard Jørgensen is a Danish businessman who currently serves as the president and chief executive officer (CEO) ofNovo Nordisk, a global healthcare company specializing in diabetes care. Jørgensen has a long history with Novo Nordisk, having joined the company in 1991 as an economist in Health Care, Economy & Planning.
Over the years,Jørgensen has held various positions within Novo Nordisk, including overseas postings in the Netherlands, the United States, and Japan, where he gained valuable international experience. In 2004, he was appointed senior vice president for IT & Corporate Development, overseeing the company's information technology functions and corporate development initiatives.
In January 2013,Jørgensen assumed the role of executive vice president and chief information officer, expanding his responsibilities to include IT, Quality & Corporate Development. He played a crucial role in driving technological advancements and ensuring quality standards across the organization. Later that year, he also took on the responsibilities for Corporate People & Organisation and Business Assurance, serving as chief of staff.
Recognizing his significant contributions and leadership capabilities,Jørgensen was appointed as the president and CEO of Novo Nordisk in January 2017. In this role, he has been instrumental in guiding the company's strategic direction and overseeing its operations worldwide. Jørgensen's deep understanding of the healthcare industry and his commitment to innovation have helped Novo Nordisk maintain its position as a global leader in diabetes care.
Outside of Novo Nordisk, Jørgensen holds the position offirst vice president of the European Federation of Pharmaceutical Industries and Associations (EFPIA). This role allows him to contribute to shaping the pharmaceutical industry and advocate for policies that promote patient access to innovative treatments.
Jørgensen holds a Master of Science (MSc) degree in Finance and Business Administration from the Aarhus School of Business, Aarhus University in Denmark. As a Danish national, he was born in November 1966. With his extensive experience and leadership in the pharmaceutical sector, Lars Fruergaard Jørgensen continues to play a significant role in advancing healthcare and improving the lives of people affected by diabetes globally.
